¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"myocardial reperfusion"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® myocardial infarction ÇÑ±Û ½É±Ù°æ»öÁõ
¼³¸í   
  ½ÉÀå¿¡ ÇǸ¦ °ø±ÞÇϴ Ç÷°üÀÌ ¸·Çô¼­, ±× µ¿¸Æ¿¡ ÀÇÇØ ¿µ¾çºÐÀ» °ø±Þ¹Þ´Â ºÎÀ§°¡ ±«»ç(Á״´ٴ ¶æ)¿¡ ºüÁö´Â °ÍÀ» ¸»ÇÔ. ÁַΠµ¿¸Æ°æÈ­Áõ(µ¿¸Æ¿¡ Áö¹æ¼ººÐ, ÁַΠÄÝ·¹½ºÅ×·Ñ µîÀÌ ½×¿© µ¿¸ÆÀÌ ±»¾î¼­ µüµüÇØÁö´Â º´Àû»óÅÂ) µîÀ¸·Î Ç÷°üÀÌ Á¼¾ÆÁ® Àִ »óÅ¿¡¼­ Ç÷Àü(ÀûÇ÷±¸, Ç÷¼ÒÆÇ µî ÇÇÀÇ ¼ººÐÀÌ ¹¶Ãļ­ ¹ß»ý) ÀÌ ¹ß»ýÇϰųª, Áö³ªÄ£ µ¿¸Æ°æÈ­ÁõÀÚü µî¿¡ ÀÇÇØ ¹ß»ýÇÑ´Ù. ÇöÀ砹̱¹ µî, ¼±Áø±¹¿¡¼­ÀÇ °¡Àå Å« »ç¸Á¿äÀÎÀÌ µÇ°í ÀÖ´Ù.¡¡ ¶ÇÇÑ ÀÌ ÁÖÀ§¿¡´Â ´ë°³ ½É±ÙÇãÇ÷ºÎÀ§°¡ Á¸ÀçÇϴµ¥ ÀÌ ºÎÀ§´Â ÇöÀç Çǰ¡ ¸ðÀÚ¶ó¼­ ¸· ±«»ç¿¡ ºüÁö±â Á÷ÀüÀÇ ¼¼Æ÷°¡ Àִ ºÎÀ§ÀÌ´Ù. µû¶ó¼­ ÀÌ ÇãÇ÷»óÅ¿¡¼­ ºü¸¥ Ä¡·á¸¦ ½ÃÇàÇÏ¿© Çǰ¡ °ø±ÞµÇ¸é, ÀÌ ºÎÀ§´Â Á¤»óÀûÀΠ»óÅ·ΠµÇ°ÚÁö¸¸, ¸¸¾à °è¼Ó ÀÌ »óÅ·ΠÀÖ°Ô µÇ¸é, ¾ðÁ¨°¡´Â ¿ª½Ã °æ»öÁõ¿¡ ºüÁ® ½ÉÀå¿îµ¿¿¡ ¸·´ëÇÑ ÁöÀåÀ» ÃÊ·¡ÇϰԠµÉ °ÍÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic myocardial hypertrophy
    Ư¹ß½É±Ùºñ´ë, ¿øÀκҸí½É±Ùºñ´ë
  • myocardial
    ½ÉÀå±ÙÀ°-, ½É±Ù-
  • myocardial anoxia
    ½É±Ù¹«»ê¼ÒÁõ, ½ÉÀå±ÙÀ°¹«»ê¼ÒÁõ
  • myocardial bridging
    ½É±Ù´Ù¸®
  • myocardial contractility
    ½É(Àå)±Ù(À°)¼öÃà·Â, ½É(Àå)±Ù(À°)¼öÃ༺
  • myocardial contraction
    ½É(Àå)±Ù(À°)¼öÃà
  • myocardial depressant factor
    ½É(Àå)±Ù(À°)¾ïÁ¦ÀÎÀÚ
  • myocardial failure
    ½É±Ù±â´É»ó½Ç, ½É±ÙºÎÀü
  • myocardial infarction
    ½É±Ù°æ»öÁõ
  • myocardial irritability
    ½É±Ù°ú¹Î¼º, ½É±ÙÀÚ±ØÈïºÐ¼º
  • myocardial ischemia
    ½É±ÙÇãÇ÷, ½ÉÀå±ÙÀ°ÇãÇ÷
  • myocardial lead
    ½É±ÙÀ¯µµ, ½ÉÀå±ÙÀ°À¯µµ
  • myocardial perfusion scintigraphy
    ½É±Ù°ü·ù¼¶±¤Á¶¿µ(¼ú)
  • myocardial scan
    ½É±Ù½ºÄµ
  • post-myocardial infarction syndrome
    ½É±Ù°æ»öÈÄÁõÈıº
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myocardial infarction
    ½É±Ù°æ»öÁõ
  • myocardial
    ½ÉÀå±ÙÀ°-, ½É±Ù-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myocardial anoxia
    ½ÉÀå±ÙÀ°¹«»ê¼ÒÁõ
  • myocardial bridging
    ½É±Ù´Ù¸®
  • myocardial contractility
    ½ÉÀå±ÙÀ°¼öÃà·Â, ½ÉÀå±ÙÀ°¼öÃ༺
  • myocardial contraction
    ½ÉÀå±ÙÀ°¼öÃà
  • myocardial failure
    ½É±Ù±â´É»ó½Ç, ½É±ÙºÎÀü
  • myocardial depressant factor
    ½ÉÀå±Ù¾ïÁ¦ÀÎÀÚ
  • idiopathic myocardial hypertrophy
    Ư¹ß½É±Ùºñ´ë, ¿øÀκҸí½É±Ùºñ´ë
  • myocardial infarction
    ½É±Ù°æ»öÁõ
  • myocardial irritability
    ½É±Ù°ú¹Î¼º, ½É±ÙÀÚ±ØÈïºÐ¼º
  • myocardial ischemia
    ½É±ÙÇãÇ÷
  • septal myocardial infarction
    Á߰ݽɱٰæ»öÁõ
  • silent myocardial infarction
    ¹«Áõ»ó½É±Ù°æ»öÁõ
  • transmural myocardial infarction
    ÀüÃþ½É±Ù°æ»öÁõ
  • myocardial lead
    ½É±ÙÀ¯µµ
  • myocardial
    ½ÉÀå±ÙÀ°-, ½É±Ù-
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Infarction, myocardial
    °æ»öÁõ(ÌÛßáñø)
  • anterior (myocardial) infarction
    Àüº®(½É±Ù)°æ»öÁõ.
  • high lateral myocardial infarction
    È޾߼øÈ¯°íÀ§Ãøº®½É±Ù°æ»öÁõ(ÍÔêÈö°ÛúãýÐÉÌÛßáñø ).
  • idiopathic myocardial hypertrophy
    Ư¹ß¼º ½É±Ùºñ´ëÁõ.
  • primary myocardial disease
    ¿ø¹ß(¼º) ½É±ÙÁúȯ(ê«Û¡àõãýÐÉòðü´).
  • primary myocardial disease
    ¿ø¹ß(¼º) ½É±ÙÁúȯ(ê«Û¡(àõ) ãýÐÉòðü´)
  • q wave,in myocardial infarction
    ½É±Ù°æ»öÀÇ (QÆÄ)(ãýÐÉÌÛßá¡­)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reperfusion injury
    Àç°ü·ù ¼Õ»ó(Àç°ü·ùáßß¿)
  • anterior (myocardial) infarction
    Àüº®(½É±Ù)°æ»öÁõ.
  • cardiac infarction =myocardial i.
    ½É±Ù°æ»öÁõ(ãýÐÉÌÛßáñø)
  • high lateral myocardial infarction
    È޾߼øÈ¯°íÀ§Ãøº®½É±Ù°æ»öÁõ(ÍÔêÈö°ÛúãýÐÉÌÛßáñø ).
  • idiopathic myocardial hypertrophy
    Ư¹ß¼º ½É±Ùºñ´ëÁõ.
  • lateral myocardial infarction
    Ãøº®½É±Ù°æ»ö(ö°ÛúãýÐÉÌãßá).
  • myocardiac,myocardial
    ½É±ÙÀÇ
  • myocardial
    ½É±Ù(ãýÐÉ)ÀÇ.
  • myocardial anoxia
    ½É±Ù¹«»ê¼ÒÁõ(ãýÐÉÙíß«áÈñø).
  • myocardial biospy
  • myocardial bridging
    ½É±Ù±³¶ô.
  • myocardial contractility
    ½É±Ù¼öÃ༺.
  • myocardial contractility
    ½É±Ù¼öÃà·Â
  • myocardial contraction
    ½É±Ù¼öÃà(¡­â¥õê).
  • myocardial contusion
    ½É±ÙÁ»ó(¡­ñ©ß¿).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Myocardial primordium
    ½ÉÀå±ÙÀ°Ãþ¿ø±â
    [¿¾ ¿ë¾î] ½É±ÙÃþ¿ø±â
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myocardial
    ½É±ÙÀÇ
  • myocardial fibrosis
    ½É±Ù¼¶À¯Áõ
  • myocardial infarction
    ½É±Ù°æ»öÁõ
  • myocardial ischemia
    ½É±ÙÇãÇ÷
  • myocardial metabolism
    ½É±Ù´ë»ç
  • myocardial necrosis
    ½É±Ù±«»ç
  • myocardial scintihraphy
    ½É±ÙÁÖ»ç¼ú
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
I/R ischemia/reperfusion
RP radial pulse; radiopharmaceutical; rapid processing [of film]; Raynaud phenomenon; reactive protein;...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
AMI acquired monosaccharide intolerance; acute myocardial infarction; amitriptyline; anterior myocardial...
IMI immunologically measurable insulin; impending myocardial infarction; Imperial Mycological Institute ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MI-R myocardial ischemia-reperfusion
I-R ischaemic-reperfusion
I-R ischemia-reperfusion injury
IRI Ischaemia-reperfusion injury
I/R Ischemia and reperfusion
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • myocardial anoxia
    ½É±Ù ¹«»ê¼ÒÁõ
  • myocardial contractility
    ½É±Ù ¼öÃà·Â
  • myocardial contusion
    ½É±Ù Á»ó
  • myocardial degeneration
    ½É±Ù º¯¼º
  • myocardial depressant factor
    ½É±Ù ¾ïÁ¦ ÀÎÀÚ
  • myocardial failure
    ½É±Ù ºÎÀü
  • myocardial function
    ½É±Ù ±â´É
  • myocardial infarction
    ½É±Ù °æ»öÁõ, ½É±Ù °æ»ö
    1. °ü»óµ¿¸ÆÀ¸·ÎºÎÅÍÀÇ Ç÷·ù°¡ µÎÀýµÇ°í ½É±ÙÀÇ ÀϺΰ¡ »ê¼Ò °áÇÌÀ¸·Î ÀÎÇØ ±«»ç¿¡ ºüÁø °ÍÀ» ¸»ÇÑ´Ù. ±«»çÀÇ ¹üÀ§¿¡ µû¶ó¼­ ¿¹ÈÄ´Â ´Ù¸¥µ¥ ÀϹÝÀûÀ¸·Î Ä¡¸í·üÀÌ ³ôÀº ÁßÁõÀÇ ÁúȯÀÌ´Ù. °ü»ó µ¿¸ÆÀÇ Á×»ó °æÈ­¿¡ µû¸¥ Æó»öÀÌ ÁÖ¿ä º´ÀÎÀ̱⠶§¹®¿¡ Áß³â ÀÌÈÄÀÇ Æ¯È÷ ³²ÀÚ¿¡°Ô¼­ ¸¹ÀÌ º¼ ¼ö ÀÖ´Ù. °ü»ó µ¿¸ÆÀÇ ¿¬ÃàÀ̳ª Æó»öÀÌ ¿øÀÎÀÌ µÇ´Â ¼öµµ ÀÖ´Ù. ÀÓ»ó Áõ»óÀº Áö¼ÓÀûÀÌ°í ½ÉÇÑ Çù½ÉÁõ°ú °°Àº ÅëÁõ ¹ßÀÛÀ» ³ªÅ¸³»°í Ç÷¾ÐÀÌ Çϰ­ÇÏ°í ¶§·Î´Â ¼îÅ© »óŰ¡ µÇ´Â ¼öµµ Àִµ¥ °ÅÀÇ Áõ»óÀÌ ¾øÀÌ °æ°úÇÏ´Â ¼öµµ ÀÖ´Ù. 2. ½É±Ù ºÎÀ§ÀÇ ÇãÇ÷¼º ±«»çÀÌ´Ù. ½É±Ù °æ»öÁõÀº ÇãÇ÷¼º ½ÉÀå ÁúȯÀÇ Ãʱâ Áõ»óÀÏ ¼ö ÀÖÁö¸¸, ȯÀÚµéÀº ±Þ¼º ½É±Ù °æ»öÁõ Àü¿¡ Çù½ÉÁõÀ» °æÇèÇÏ°Ô µÈ´Ù. ½É±Ù °æ»öÁõÀÇ ÀÓ»óÀû ÇüÅ´ °æµµÀÇ °æ¿ìºÎÅÍ ÀϽÃÀû Çù½ÉÁõÀÇ Áõ»ó±îÁö ´Ù¾çÇѵ¥ ÀÌ·¯ÇÑ ÀϽÃÀûÀÎ Áõ»ó¿¡´Â ½É±Ù ±«»ç¸¦ ÀÏÀ¸Å°´Â °Í°ú °°Àº ½ÇÁ¦ÀûÀÎ Áø´ÜÀº ³»·ÁÁöÁö ¾Ê´Â´Ù. ´ÙÀ½°ú °°Àº 3°¡Áö ÈÄÀ¯ÁõÀÌ ¸ðµç ½É±Ù °æ»öÁõ ȯÀڵ鿡°Ô¼­ ³ªÅ¸³­´Ù. 1
  • myocardial irritability
    ½É±Ù °ú¹Î¼º, ½É±Ù ÀÚ±Ø ÈïºÐ¼º
  • myocardial lead
    ½É±Ù À¯µµ
  • myocardial necrosis
    ½É±Ù ±«»ç
  • myocardial primordium
    ½ÉÀå ±ÙÀ°Ãþ ¿ø±â
  • myocardial scan
    ½É±Ù ÁÖ»ç
  • myocardial stimulants
    ½É±Ù ÀÚ±ØÁ¦
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
myocardial reperfusion Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing myocardial reperfusion injury.
(12 Dec 1998)
myocardial reperfusion injury Functional, metabolic, or structural changes in ischemic heart muscle thought to result from reperfusion to the ischemic areas. Changes can be fatal to muscle cells and may include oedema with explosive cell swelling and disintegration, sarcolemma disruption, fragmentation of mitochondria, contraction band necrosis, enzyme washout, and calcium overload. Other damage may include haemorrhage and ventricular arrhythmias. One possible mechanism of damage is thought to be oxygen free radicals. Treatment currently includes the introduction of scavengers of oxygen free radicals, and injury is thought to be prevented by warm blood cardioplegic infusion prior to reperfusion.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
reperfusion The restoration of blood flow to an organ or tissue. After a heart attack, an immediate goal is to quickly open blocked arteries and reperfuse the heart muscles. Early reperfusion minimises the extent of heart muscle damage and preserves the pumping function of the heart.
(12 Dec 1998)
reperfusion injury Functional, metabolic, or structural changes, including necrosis, in ischemic tissues thought to result from reperfusion to ischemic areas of the tissue. The most common instance is myocardial reperfusion injury.
(12 Dec 1998)
anterior myocardial infarction Infarction involving the anterior wall of the heart, and producing indicative electrocardiographic changes in the anterior chest leads and often in limb lead I.
(05 Mar 2000)
anteroinferior myocardial infarction Infarction involving both anterior and inferior walls of the heart simultaneously.
(05 Mar 2000)
anterolateral myocardial infarction Extensive anterior infarction producing indicative changes across the precordium as well as in leads I and aVL.
(05 Mar 2000)
anteroseptal myocardial infarction An anterior infarction in which indicative electrocardiographic changes are confined to the medial chest leads (V1-V4).
(05 Mar 2000)
biopsy, myocardial <investigation, procedure, surgery> A procedure which involves the removal of a small specimen of cardiac muscle tissue for microscopic analysis.
This is generally performed at the same time as a cardiac catheterisation or as a very similar, yet separate, procedure. A small piece of heart tissue is taken via a small forceps inserted into the cardiac catheter site (usually threaded through a vein in the neck).
This test may reveal the cause of a cardiomyopathy, myocarditis, amyloidosis or a heart transplant rejection.
(21 Mar 1998)
myocardial Refers to the heart's muscle mass.
(09 Oct 1997)
myocardial biopsy <procedure> A procedure which involves the removal of a small specimen of cardiac muscle tissue for microscopic analysis.
This is generally performed at the same time as a cardiac catheterisation or as a very similar, yet separate, procedure. A small piece of heart tissue is taken via a small forceps inserted into the cardiac catheter site (usually threaded through a vein in the neck). This test may reveal the cause of a cardiomyopathy, myocarditis, amyloidosis or a heart transplant rejection.
(27 Sep 1997)
myocardial bridge A bridge of cardiac muscle fibres extending over the epicardial aspect of a coronary artery; this finding, in cases of sudden unexpected death, has led to speculation that cardiac contraction during exertion could constrict the coronary artery.
(05 Mar 2000)
myocardial contraction Contractile activity of the heart.
(12 Dec 1998)
myocardial contusion A bruise to the heart muscle, usually caused by a blunt force applied to the anterior thorax (motor vehicle accident). Commonly seen in association with a rib or sternum fracture. Complications include cardiac arrhythmias and death.
(27 Sep 1997)
myocardial depressant factor A low molecular weight peptide of about 800-1000 having a negative inotropic effect. It is released into the circulation during experimental haemorrhagic pancreatitis, severe ischemia, and postoligaemic shock.
(12 Dec 1998)
myocardial diseases Diseases of the myocardium.
(12 Dec 1998)
myocardial infarct imaging <radiology> Tc-99m pyrophosphate (PYP) 20 mCi, peak abnormality 2-3 days, often falsely negative before 2 days, abnormal for 7-10 days, mechanism: calcium influx into ischemic cells, PYP incorporated into crystalline structure, analogous to hydroxyapatite see: nuclear cardiology
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 2 ÆäÀÌÁö: 1
  • Myocardial Reperfusion - »õâ Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing MYOCARDIAL REPERFUSION INJURY.
    Synonyms : Coronary Reperfusions, Myocardial Reperfusions, Reperfusion, Coronary, Reperfusions, Coronary, Reperfusions, Myocardial
  • Myocardial Reperfusion Injury - »õâ Damage to the MYOCARDIUM resulting from reperfusion of ischemic areas of the HEART. Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm. Reperfusion can cause EDEMA, injuries to cardiac myocytes (MYOCYTES, CARDIAC) and the conducting tissue with resultant ARRHYTHMIA. Degree of injury depends on the duration and extent of MYOCARDIAL ISCHEMIA before reperfusion, cytosolic calcium overload, and oxygen FREE RADICALS.
    Synonyms : Injury, Myocardial Reperfusion, Myocardial Ischemic Reperfusion Injury, Injuries, Myocardial Reperfusion, Myocardial Reperfusion Injuries, Reperfusion Injuries, Myocardial
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myocardial
    ½É±ÕÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á